Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins.
D000818:Animals; D000862:Ant Venoms / Q000276:immunology / Q000302:isolation & purification / Q000494:pharmacology*; D000893:Anti-Inflammatory Agents; D000917:Antibody Formation; D001180:Arthropod Venoms / Q000494:pharmacology*; D002850:Chromatography, Gel; D003172:Complement C1 / Q000378:metabolism; D003175:Complement C2 / Q000378:metabolism; D003181:Complement C4 / Q000378:metabolism; D003169:Complement Inactivator Proteins / Q000378:metabolism*; D003165:Complement System Proteins / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D005779:Immunodiffusion; D011817:Rabbits
D000862:Ant Venoms; D000893:Anti-Inflammatory Agents; D001180:Arthropod Venoms; D003172:Complement C1; D003175:Complement C2; D003181:Complement C4; D003169:Complement Inactivator Proteins; D003165:Complement System Proteins